When a study depends on the integrity of the drug being administered, any excursions can compromise the entire clinical trial. We understand this better than anyone because life science is our business, led by pharmaceutical industry experts with deep knowledge of logistics and pharma regulations. Our global Pharmaceutical Service Network is purpose-built for the secure storage and distribution of your valuable IMPs and medical devices, while our temperature-controlled depots offer an additional host of services. Learn more.
5 Tips To Optimize The Biomanufacturing Supply Chain By Rick Johnston, Ph.D. Founder & Principal, Bioproduction Group, BIO-G
This white paper addresses ways of modeling biomanufacturing networks that explicitly account for supply chain risks. Capturing the likelihood and effect of risks is a critical first step in determining how much inventory is needed to buffer against adverse events, and therefore the level of safety stocks that are required.
How RFID Is Changing The Pharma Cold Chain By Lee Marts, Quality Assurance and Regulatory Affairs Manager, American Thermal Instruments, Inc
Many companies consider wireless technologies to improve temperature monitoring efficiency. RFID is a primary component of this approach. In common usage for the past 20 years, RFID loggers (i.e. tags) store product information in a similar fashion to bar codes. Unlike bar codes, however, they wirelessly transmit data without requiring a clear sightline or close contact with a reader.
Now in its 14th year, TIDES® continues to build upon its reputation as the place to meet all the important players in the oligonucleotide and peptide therapeutics industries, from discovery all the way through manufacturing. Attendees will have access to all four conference tracks:
• Oligonucleotide and Peptide Manufacturing Technology and Product Development
• Oligonucleotide Therapeutics Discovery
• Nucleic Acids Technologies for Molecular Diagnostics
• Peptide Discovery and Development
Spotlight On Supply Chain
Quality In The Global Pharmaceutical Supply Chain Although regulations and guidelines are already in place in multiple industries, supply chain complexity has grown from simple domestic sourcing, manufacturing, and distribution, to a complex evolution of global sourcing, manufacturing, and distribution centers around the world.
Does Joint Auditing Work? A Look Into The Rx-360 Pilot Program Rx-360, an international pharmaceutical and biotech industry supply chain consortium, has set up a program of joint audits. The goal of this project is to expand audit coverage and reduce duplicated audit efforts. Here we discuss how the joint audits work and what the advantages are for both pharmaceutical companies and their suppliers.